TrialSignal
Clinical trial intelligence report
Efficacy of Shen Cao Gan Jiang Tang (Gan Cao Gan Jiang Tang With Ginseng) on Mild and Moderate COVID-19 Patients: A Multicenter, Prospective, Randomized Controlled Trial
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT05055427
Status
COMPLETED
Phase
Phase 2/3
Sponsor
University of Medicine and Pharmacy at Ho Chi Minh City
Executive brief
Investment-Ready Snapshot
This clinical trial evaluates the efficacy of Shen Cao Gan Jiang Tang, a traditional herbal formula, in treating mild and moderate COVID-19 patients. Conducted by the University of Medicine and Pharmacy at Ho Chi Minh City, the study aims to assess its impact on symptom duration, severity, and progression to severe disease compared to standard care.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT05055427
Indication
COVID-19 Respiratory Infection
Modality
small molecule
Target
COVID-19
Intervention
Shen Cao Gan Jiang Tang (Gan Cao Gan Jiang Tang with Ginseng)
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.